CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma	Large B-Cell Lymphoma (LBCL)	Recruiting	Phase 2	2026-04-07		NCT04661020

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Yake Biotechnology Ltd.	30
Zhejiang University	194

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital，College of Medicine, Zhejiang University	Hangzhou	China	8

Clinical trials